Spectrum of Mesenchymal–Epithelial Transition Aberrations and Potential Clinical Implications: Insights From Integrative Pancancer Analysis

BACKGROUND: The receptor tyrosine kinase mesenchymal–epithelial transition factor (MET) is frequently altered in cancers and is a common therapeutic target for cancers with MET variants. However, abnormal MET alterations and their associations with patient outcome across different cancer types have...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Juanni, Hu, Kuan, Zhou, Lei, Huang, Jinzhou, Zeng, Shuangshuang, Xu, Zhijie, Yan, Yuanliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593712/
https://www.ncbi.nlm.nih.gov/pubmed/33178590
http://dx.doi.org/10.3389/fonc.2020.560615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593712/
https://www.ncbi.nlm.nih.gov/pubmed/33178590
http://dx.doi.org/10.3389/fonc.2020.560615

Ejemplares similares